Trial By Error: An Interview with Sjoerd Beentjes, Lead Author of Big Data Study on “Blood-Based Biomarkers” for ME/CFS| virology.ws
By David Tuller, DrPH If the results for a trial’s primary outcome do not meet the threshold for what is considered a “clinically significant” benefit, it g ...| Virology Blog
By David Tuller, DrPH I have written frequently about Cochrane, the organization renowned for its systematic reviews of medical interventions, and its deepl ...| Virology Blog
Trial By Error: A Reprise of a 2018 Post on My Visits with Alem Matthees| virology.ws